Loading Events

« All Events

  • This event has passed.

BIOTechno Forum Paris 2018

June 11


CLICK HERE TO FIND OUT MORE

BIOTechno Forum Paris

22nd edition: 11 June, Paris, France

The “Forum BIOTechno PARIS” is an annual forum that brings together biotechnology actors. This forum is one of the Forums organized by the national network “Réseau BIOTechno” that are held in various cities in France. This event aims to review biotechnology advance and related domains, to connect young researcher together and with industrial actors and to help them build their career plan.

For this 22nd edition, more than 350 attendees, exhibitors, and speakers are expected on 11th of June 2018 at the Espace Saint Martin to meet and exchange. This 2018 edition will be mentored by Pr. Pierre Monsan, co-founder, and director of Toulouse White Biotechnology and the French federation of biotechnologies.

This day will be animated by conferences, roundtables and workshops, and young scientists will have the opportunity to meet and exchange with actors of the biotechnology domain (food-tech, med-tech, bio-techs…). Guest speakers from industry, business school, institutions, consulting companies, start-ups or associations will share their experience regarding their job, their business, and the existing job market for scientists.

For more information and registration please visit www.reseau-biotechno.com/forum-biotechno-paris/

NB: This french local edition will be followed by an international one, in English that will take place in Strasbourg from 28th to 30th November 2018. For more information about this international edition, please visit the dedicated page.

CLICK HERE TO FIND OUT MORE

Details

Date:
June 11
Event Category:
Website:
http://www.reseau-biotechno.com/forum-biotechno-paris/

Organizer

Réseau BIOTechno
Website:
www.reseau-biotechno.com

Venue

Espace Saint Martin
199 bis, rue Saint-Martin
Paris, 75003 France
+ Google Map
Website:
http://www.espacesaintmartin.com/en

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and it's freely accessible content.